We invest in Western greentech, biotech and software companies for the sole purpose of expanding those companies to cover the technological demand in China.
The targets are globally leading tech companies. All targets are selected based on our specific “China ready” selection criteria, which covers their technology, operations and management.
The post-investment value add of active China expansion is significant. Once the expansion gains traction, the target has access to one of the world’s largest and fastest growing market. Being able to capture a market share proves that the company can execute and compete. This drives the global valuation rapidly higher and makes the company a preferred acquisition target or IPO candidate.
In executing this investment strategy, our funds offer investors the following 3 advantages:
As an investing expansion partner, LvS has preferential access to high-tech companies and is generally able to invest at preferential terms
Expansion to China provides exposure to high growth without the challenges of direct investment in Chinese companies.
Our active management of the expansion provides supervision and insight that board positions cannot achieve.
Invests in leading global companies in new energy and digital technology.
Invests in global biotech and medical technology companies.